Share chart Harmony Biosciences Holdings, Inc.
Extended chart
Simple chart
About Harmony Biosciences Holdings, Inc.
Harmony Biosciences Holdings, Inc., фармацевтическая компания на коммерческой стадии, специализируется на разработке и коммерциализации методов лечения пациентов с редкими неврологическими расстройствами. Его ведущий продукт включает ВАКИКС (питолизант) для лечения педиатрических пациентов, страдающих нарколепсией. Harmony Biosciences Holdings, Inc. ранее была известна как Harmony Biosciences II, Inc. и изменила свое название на Harmony Biosciences Holdings, Inc. в феврале 2020 года. Компания была основана в 2017 году и базируется в Плимуте, штат Пенсильвания.| IPO date | 2020-08-19 |
|---|---|
| ISIN | US4131971040 |
| Industry | Pharmaceuticals |
| Sector | Health Care |
| Валюта | usd |
| Валюта отчета | usd |
| Див.доход ао | 0 |
| Сайт | http://www.harmonybiosciences.com |
| Цена ао | 32.99 |
| Change price per day: | +0.6209% (28.99) |
|---|---|
| Change price per week: | -0.3076% (29.26) |
| Change price per month: | -13.18% (33.6) |
| Change price per 3 month: | -13.85% (33.86) |
| Change price per half year: | -17.78% (35.48) |
| Change price per year: | -1.12% (29.5) |
| Change price per 3 year: | -35.32% (45.1) |
| Change price per year to date: | -13.26% (33.63) |
|
|
Underestimation
|
Efficiency
|
|||||||||||||||||||||||||||||||||||||
Dividends
|
Debt
|
Growth impulse
|
|||||||||||||||||||||||||||||||||||||
| Institutions | Volume | Share, % |
|---|---|---|
| Valor Management LLC | 11218033 | 19.76 |
| Blackrock Inc. | 6003327 | 10.57 |
| FMR, LLC | 5276825 | 9.3 |
| Vanguard Group Inc | 3674764 | 6.47 |
| Vivo Capital, LLC | 2606247 | 4.59 |
| State Street Corporation | 1360447 | 2.4 |
| Pacer Advisors, INC. | 1224910 | 2.16 |
| Morgan Stanley | 1086215 | 1.91 |
| venBio Partners LLC | 1035396 | 1.82 |
| Camber Capital Management LP | 750000 | 1.32 |
| ETF | Share, % | Profitability for 1 year, % | Dividends, % |
|---|---|---|---|
| Syntax Stratified SmallCap ETF | 0.32456 | 13.51 | 1.639 |
| Future Tech ETF | 0.21704 | 426.34 | 0.8416 |
| Principal Healthcare Innovators ETF | 0.21704 | 618.5 | 0.8416 |
| iShares Morningstar Small-Cap Growth ETF | 0.05375 | 596.94 | 0.72598 |
| iShares Morningstar Small-Cap ETF | 0.02711 | 391.25 | 1.60498 |
| 0.17 | 409.31 | 1.13 |
| Head | Job title | Payment | Year of birth |
|---|---|---|---|
| Mr. Jeffrey S. Aronin | Founder & Non-Executive Chairman | 19.6k | 1968 (57 years) |
| Mr. Jeffrey Dierks M.B.A. | Executive VP & Chief Commercial Officer | 662.1k | 1972 (53 years) |
| Mr. David Bradshaw | Head of Technical Operations | N/A | |
| Mr. Christian Ulrich | General Counsel & Corporate Secretary | N/A | |
| Dr. Jeffrey M. Dayno M.D. | President, CEO & Director | 762.15k | 1957 (68 years) |
| Mr. Andrew Serafin J.D., M.B.A. | Executive VP & Chief Strategy Officer | 605.42k | 1975 (50 years) |
| Ms. Tricia Glover | Chief Compliance Officer | N/A | |
| Dr. Kumar Budur M.D., M.S. | Executive VP and Chief Medical & Scientific Officer | ||
| Brennan Doyle | VP & Head of Investor Relations | ||
| Mr. Sandip S. Kapadia CPA, M.B.A. | Executive VP, Chief Administrative Officer & CFO | 1970 (55 years) |
Address: United States, Plymouth Meeting, 630 West Germantown Pike - open in Google maps, open in Yandex maps
Website: http://www.harmonybiosciences.com
Website: http://www.harmonybiosciences.com
